Recently, KRAS mutations have been reported to be involved in human cancer, including nasopharyngeal carcinoma [21], ovarian cancer [22], lung cancer [23], pancreatic cancer [24], oral squamous cell carcinoma [25], esophageal squamous cell carcinoma [26], colorectal cancer [27], breast cancer [28] and so on. This evidence concerns the gene KRAS and breast carcinoma.